Literature DB >> 22728826

Altered BCR signalling quality predisposes to autoimmune disease and a pre-diabetic state.

Sebastian Königsberger1, Jan Prodöhl, David Stegner, Vanessa Weis, Martin Andreas, Martin Stehling, Theresa Schumacher, Ruben Böhmer, Ina Thielmann, Judith M M van Eeuwijk, Bernhard Nieswandt, Friedemann Kiefer.   

Abstract

The spleen tyrosine kinase family members Syk and Zap-70 are pivotal signal transducers downstream of antigen receptors and exhibit overlapping expression patterns at early lymphocytic developmental stages. To assess their differential kinase fitness in vivo, we generated mice, which carry a Zap-70 cDNA knock-in controlled by intrinsic Syk promoter elements that disrupts wild-type Syk expression. Kinase replacement severely compromised Erk1/2-mediated survival and proper selection of developing B cells at central and peripheral checkpoints, demonstrating critical dependence on BCR signalling quality. Furthermore, ITAM- and hemITAM-mediated activation of platelets and neutrophils was completely blunted, while surprisingly FcγR-mediated phagocytosis in macrophages was retained. The alteration in BCR signalling quality resulted in preferential development and survival of marginal zone B cells and prominent autoreactivity, causing the generation of anti-insulin antibodies and age-related glomerulonephritis. Development of concomitant fasting glucose intolerance in knock-in mice highlights aberrant B cell selection as a potential risk factor for type 1 diabetes, and suggests altered BCR signalling as a mechanism to cause biased cellular and Ig repertoire selection, ultimately contributing to B cell-mediated autoimmune predisposition.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22728826      PMCID: PMC3411075          DOI: 10.1038/emboj.2012.169

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  60 in total

1.  The SH2 domain containing tyrosine phosphatase-1 down-regulates activation of Lyn and Lyn-induced tyrosine phosphorylation of the CD19 receptor in B cells.

Authors:  A K Somani; K Yuen; F Xu; J Zhang; D R Branch; K A Siminovitch
Journal:  J Biol Chem       Date:  2000-10-20       Impact factor: 5.157

2.  Molecular cloning of a porcine gene syk that encodes a 72-kDa protein-tyrosine kinase showing high susceptibility to proteolysis.

Authors:  T Taniguchi; T Kobayashi; J Kondo; K Takahashi; H Nakamura; J Suzuki; K Nagai; T Yamada; S Nakamura; H Yamamura
Journal:  J Biol Chem       Date:  1991-08-25       Impact factor: 5.157

3.  Matching of oligoclonal immunoglobulin transcriptomes and proteomes of cerebrospinal fluid in multiple sclerosis.

Authors:  Birgit Obermeier; Reinhard Mentele; Joachim Malotka; Josef Kellermann; Tania Kümpfel; Hartmut Wekerle; Friedrich Lottspeich; Reinhard Hohlfeld; Klaus Dornmair
Journal:  Nat Med       Date:  2008-05-18       Impact factor: 53.440

4.  Differential intrinsic enzymatic activity of Syk and Zap-70 protein-tyrosine kinases.

Authors:  S Latour; L M Chow; A Veillette
Journal:  J Biol Chem       Date:  1996-09-13       Impact factor: 5.157

5.  Impaired precursor B cell differentiation in Bruton's tyrosine kinase-deficient mice.

Authors:  Sabine Middendorp; Gemma M Dingjan; Rudolf W Hendriks
Journal:  J Immunol       Date:  2002-03-15       Impact factor: 5.422

6.  Perinatal lethality and blocked B-cell development in mice lacking the tyrosine kinase Syk.

Authors:  M Turner; P J Mee; P S Costello; O Williams; A A Price; L P Duddy; M T Furlong; R L Geahlen; V L Tybulewicz
Journal:  Nature       Date:  1995-11-16       Impact factor: 49.962

7.  A hypomorphic allele of ZAP-70 reveals a distinct thymic threshold for autoimmune disease versus autoimmune reactivity.

Authors:  Lih-Yun Hsu; Ying Xim Tan; Zheng Xiao; Marie Malissen; Arthur Weiss
Journal:  J Exp Med       Date:  2009-10-19       Impact factor: 14.307

8.  Erk kinases link pre-B cell receptor signaling to transcriptional events required for early B cell expansion.

Authors:  Tomoharu Yasuda; Hideki Sanjo; Gilles Pagès; Yohei Kawano; Hajime Karasuyama; Jacques Pouysségur; Masato Ogata; Tomohiro Kurosaki
Journal:  Immunity       Date:  2008-03-20       Impact factor: 31.745

9.  CLEC-2 is an essential platelet-activating receptor in hemostasis and thrombosis.

Authors:  Frauke May; Ina Hagedorn; Irina Pleines; Markus Bender; Timo Vögtle; Johannes Eble; Margitta Elvers; Bernhard Nieswandt
Journal:  Blood       Date:  2009-07-29       Impact factor: 22.113

10.  Resolution and characterization of pro-B and pre-pro-B cell stages in normal mouse bone marrow.

Authors:  R R Hardy; C E Carmack; S A Shinton; J D Kemp; K Hayakawa
Journal:  J Exp Med       Date:  1991-05-01       Impact factor: 14.307

View more
  11 in total

Review 1.  The role of tyrosine kinases in systemic lupus erythematosus and their potential as therapeutic targets.

Authors:  Wen-Hai Shao; Philip L Cohen
Journal:  Expert Rev Clin Immunol       Date:  2014-03-29       Impact factor: 4.473

2.  A systems toxicology approach identifies Lyn as a key signaling phosphoprotein modulated by mercury in a B lymphocyte cell model.

Authors:  Joseph A Caruso; Paul M Stemmer; Alan Dombkowski; Nicholas J Caruthers; Randall Gill; Allen J Rosenspire
Journal:  Toxicol Appl Pharmacol       Date:  2014-01-14       Impact factor: 4.219

Review 3.  Autoimmunity checkpoints as therapeutic targets in B cell malignancies.

Authors:  Markus Müschen
Journal:  Nat Rev Cancer       Date:  2018-01-05       Impact factor: 60.716

4.  Targeted downregulation of platelet CLEC-2 occurs through Syk-independent internalization.

Authors:  Viola Lorenz; David Stegner; Simon Stritt; Timo Vögtle; Friedemann Kiefer; Walter Witke; Jürgen Schymeinsky; Steve P Watson; Barbara Walzog; Bernhard Nieswandt
Journal:  Blood       Date:  2015-03-20       Impact factor: 22.113

5.  Developmental partitioning of SYK and ZAP70 prevents autoimmunity and cancer.

Authors:  Teresa Sadras; Mickaël Martin; Kohei Kume; Mark E Robinson; Supraja Saravanakumar; Gal Lenz; Zhengshan Chen; Joo Y Song; Tanya Siddiqi; Laura Oksa; Anne Marie Knapp; Jevon Cutler; Kadriye Nehir Cosgun; Lars Klemm; Veronika Ecker; Janet Winchester; Dana Ghergus; Pauline Soulas-Sprauel; Friedemann Kiefer; Nora Heisterkamp; Akhilesh Pandey; Vu Ngo; Lili Wang; Hassan Jumaa; Maike Buchner; Jürgen Ruland; Wing-Chung Chan; Eric Meffre; Thierry Martin; Markus Müschen
Journal:  Mol Cell       Date:  2021-04-19       Impact factor: 17.970

6.  Integrin CD11b Negatively Regulates B Cell Receptor Signaling to Shape Humoral Response during Immunization and Autoimmunity.

Authors:  Mingqian Zhou; Paul Dascani; Chuanlin Ding; Justin T Kos; David Tieri; Xiaoying Lin; Dawn Caster; David Powell; Chengping Wen; Corey T Watson; Jun Yan
Journal:  J Immunol       Date:  2021-09-01       Impact factor: 5.426

7.  Identification and Characterization of Post-activated B Cells in Systemic Autoimmune Diseases.

Authors:  Sarah Y Weißenberg; Franziska Szelinski; Eva Schrezenmeier; Ana-Luisa Stefanski; Annika Wiedemann; Hector Rincon-Arevalo; Anna Welle; Annemarie Jungmann; Karl Nordström; Jörn Walter; Juliana Imgenberg-Kreuz; Gunnel Nordmark; Lars Rönnblom; Prathyusha Bachali; Michelle D Catalina; Amrie C Grammer; Peter E Lipsky; Andreia C Lino; Thomas Dörner
Journal:  Front Immunol       Date:  2019-09-24       Impact factor: 7.561

8.  An Ancient BCR-like Signaling Promotes ICP Production and Hemocyte Phagocytosis in Oyster.

Authors:  Jiejie Sun; Lingling Wang; Chuanyan Yang; Linsheng Song
Journal:  iScience       Date:  2020-01-11

9.  Critical Role for an acidic amino acid region in platelet signaling by the HemITAM (hemi-immunoreceptor tyrosine-based activation motif) containing receptor CLEC-2 (C-type lectin receptor-2).

Authors:  Craig E Hughes; Uma Sinha; Anjali Pandey; Johannes A Eble; Christopher A O'Callaghan; Steve P Watson
Journal:  J Biol Chem       Date:  2012-12-21       Impact factor: 5.157

Review 10.  Therapeutic implications of the anergic/postactivated status of B cells in systemic lupus erythematosus.

Authors:  Thomas Dörner; Franziska Szelinski; Andreia C Lino; Peter E Lipsky
Journal:  RMD Open       Date:  2020-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.